Picture of BoneSupport Holding AB logo

BONEX — BoneSupport Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Bonesupport To Submit A De Novo Application In April 2020

March 23 (Reuters) - Bonesupport Holding AB  BONEX.ST :
    * COMPANY WILL SUBMIT A DE NOVO APPLICATION TO US FOOD AND
DRUG
ADMINISTRATION (FDA) TO OBTAIN A MARKET APPROVAL FOR COMPANY'S
ANTIBIOTIC-RELEASING PRODUCT CERAMENT G
    * APPLICATION CAN POTENTIALLY RESULT IN AN APPROVAL AT
LATTER END
OF 2020
    * DIALOGUE WITH FDA HAS RESULTED IN CERAMENT G BEING GRANTED
DESIGNATION AS BREAKTHROUGH DEVICE
    * CO HAS DECIDED TO SUBMIT A DE NOVO APPLICATION IN APRIL
2020

Source text for Eikon:  ID:nWkr1t951Q 
Further company coverage:  BONEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on BoneSupport Holding AB

See all news